de Beaufort C E, Reunanen A, Raleigh V, Storms F, Kleinebreil L, Gallego R, Giorda C, Midthjell K, Jecht M, de Leeuw I, Schober E, Boran G, Tolis G
Clinique Pediatrique Luxemburg, GD de Luxemburg.
Eur J Public Health. 2003 Sep;13(3 Suppl):51-4. doi: 10.1093/eurpub/13.suppl_1.51.
Diabetes mellitus is one of the major causes of morbidity and mortality in EU/EFTA countries. Monitoring risk factors for diabetes and its complications will offer the possibility to evaluate the development in time as well as the influence of possible interventions. In this investigation a list with core and secondary indicators is proposed. Availability of these indicators and their data sources is discussed. An important variability of data sources is used in EU/EFTA countries, interfering with the comparability of the outcome. Further harmonisation as well as continuous evaluation of data sources will be necessary to provide reliable tools to monitor diabetes mellitus and its outcome on a routine basis.
糖尿病是欧盟/欧洲自由贸易联盟国家发病和死亡的主要原因之一。监测糖尿病及其并发症的风险因素将为及时评估病情发展以及可能干预措施的影响提供可能。在本调查中，提出了一份核心指标和次要指标清单，并讨论了这些指标的可用性及其数据来源。欧盟/欧洲自由贸易联盟国家使用的数据来源存在重要差异，这影响了结果的可比性。为了提供可靠的工具以便常规监测糖尿病及其结果，有必要进一步统一并持续评估数据来源。
